Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

LifeStance Health (LFST) EBIT Margin: 2019-2024

Historic EBIT Margin for LifeStance Health (LFST) over the last 5 years, with FY2024 value amounting to 2.53%.

  • LifeStance Health's EBIT Margin rose 20200.0% to 2.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year increase of 59100.0%. This contributed to the annual value of 2.53% for FY2024, which is 153900.0% up from last year.
  • According to the latest figures from FY2024, LifeStance Health's EBIT Margin is 2.53%, which was up 153900.0% from 17.92% recorded in FY2023.
  • Over the past 5 years, LifeStance Health's EBIT Margin peaked at 2.53% during FY2024, and registered a low of 42.9% during FY2021.
  • In the last 4 years, LifeStance Health's EBIT Margin had a median value of 21.18% in 2023 and averaged 21.95%.
  • In the last 5 years, LifeStance Health's EBIT Margin soared by 184500bps in 2022 and then skyrocketed by 65400bps in 2023.
  • Over the past 4 years, LifeStance Health's EBIT Margin (Annual) stood at 42.9% in 2021, then surged by 43bps to 24.45% in 2022, then rose by 27bps to 17.92% in 2023, then skyrocketed by 86bps to 2.53% in 2024.
  • Its EBIT Margin was 2.53% in FY2024, compared to 17.92% in FY2023 and 24.45% in FY2022.